世界のPD-1＆PD-L1免疫療法市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global PD-1 and PD-L1 Immunotherapy Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4668
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、106ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、PD-1＆PD-L1免疫療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PD-1阻害剤、PD-L1阻害剤）、用途別市場規模（固形腫瘍、血液関連腫瘍）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・PD-1＆PD-L1免疫療法の市場動向
・企業の競争状況、市場シェア
・PD-1＆PD-L1免疫療法の種類別市場規模と予測2016-2027（PD-1阻害剤、PD-L1阻害剤）
・PD-1＆PD-L1免疫療法の用途別市場規模と予測2016-2027（固形腫瘍、血液関連腫瘍）
・PD-1＆PD-L1免疫療法の北米市場規模2016-2027（アメリカ、カナダ）
・PD-1＆PD-L1免疫療法の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・PD-1＆PD-L1免疫療法のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・PD-1＆PD-L1免疫療法の中南米市場規模2016-2027（メキシコ、ブラジル）
・PD-1＆PD-L1免疫療法の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（AstraZeneca、Bristol-Myers Squibb、F. Hoffmann-La Roche、Merck、Pfizer、Roche、Novartis、Jiangsu HengRui Medicine、Innovent、Eli Lilly、GlaxoSmithKline）
・結論

Market Analysis and Insights: Global PD-1 and PD-L1 Immunotherapy Market
The global PD-1 and PD-L1 Immunotherapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global PD-1 and PD-L1 Immunotherapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global PD-1 and PD-L1 Immunotherapy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global PD-1 and PD-L1 Immunotherapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global PD-1 and PD-L1 Immunotherapy market.

Global PD-1 and PD-L1 Immunotherapy Scope and Market Size
PD-1 and PD-L1 Immunotherapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global PD-1 and PD-L1 Immunotherapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
PD-1 inhibitor
PD-L1 inhibitor

Segment by Application
Solid Tumors
Blood-related Tumors

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AstraZeneca
Bristol-Myers Squibb
F. Hoffmann-La Roche
Merck
Pfizer
Roche
Novartis
Jiangsu HengRui Medicine
Innovent
Eli Lilly
GlaxoSmithKline

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global PD-1 and PD-L1 Immunotherapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 PD-1 inhibitor
1.2.3 PD-L1 inhibitor
1.3 Market by Application
1.3.1 Global PD-1 and PD-L1 Immunotherapy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Solid Tumors
1.3.3 Blood-related Tumors
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global PD-1 and PD-L1 Immunotherapy Market Perspective (2016-2027)
2.2 PD-1 and PD-L1 Immunotherapy Growth Trends by Regions
2.2.1 PD-1 and PD-L1 Immunotherapy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 PD-1 and PD-L1 Immunotherapy Historic Market Share by Regions (2016-2021)
2.2.3 PD-1 and PD-L1 Immunotherapy Forecasted Market Size by Regions (2022-2027)
2.3 PD-1 and PD-L1 Immunotherapy Industry Dynamic
2.3.1 PD-1 and PD-L1 Immunotherapy Market Trends
2.3.2 PD-1 and PD-L1 Immunotherapy Market Drivers
2.3.3 PD-1 and PD-L1 Immunotherapy Market Challenges
2.3.4 PD-1 and PD-L1 Immunotherapy Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top PD-1 and PD-L1 Immunotherapy Players by Revenue
3.1.1 Global Top PD-1 and PD-L1 Immunotherapy Players by Revenue (2016-2021)
3.1.2 Global PD-1 and PD-L1 Immunotherapy Revenue Market Share by Players (2016-2021)
3.2 Global PD-1 and PD-L1 Immunotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by PD-1 and PD-L1 Immunotherapy Revenue
3.4 Global PD-1 and PD-L1 Immunotherapy Market Concentration Ratio
3.4.1 Global PD-1 and PD-L1 Immunotherapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by PD-1 and PD-L1 Immunotherapy Revenue in 2020
3.5 PD-1 and PD-L1 Immunotherapy Key Players Head office and Area Served
3.6 Key Players PD-1 and PD-L1 Immunotherapy Product Solution and Service
3.7 Date of Enter into PD-1 and PD-L1 Immunotherapy Market
3.8 Mergers & Acquisitions, Expansion Plans

4 PD-1 and PD-L1 Immunotherapy Breakdown Data by Type
4.1 Global PD-1 and PD-L1 Immunotherapy Historic Market Size by Type (2016-2021)
4.2 Global PD-1 and PD-L1 Immunotherapy Forecasted Market Size by Type (2022-2027)

5 PD-1 and PD-L1 Immunotherapy Breakdown Data by Application
5.1 Global PD-1 and PD-L1 Immunotherapy Historic Market Size by Application (2016-2021)
5.2 Global PD-1 and PD-L1 Immunotherapy Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America PD-1 and PD-L1 Immunotherapy Market Size (2016-2027)
6.2 North America PD-1 and PD-L1 Immunotherapy Market Size by Type
6.2.1 North America PD-1 and PD-L1 Immunotherapy Market Size by Type (2016-2021)
6.2.2 North America PD-1 and PD-L1 Immunotherapy Market Size by Type (2022-2027)
6.2.3 North America PD-1 and PD-L1 Immunotherapy Market Size by Type (2016-2027)
6.3 North America PD-1 and PD-L1 Immunotherapy Market Size by Application
6.3.1 North America PD-1 and PD-L1 Immunotherapy Market Size by Application (2016-2021)
6.3.2 North America PD-1 and PD-L1 Immunotherapy Market Size by Application (2022-2027)
6.3.3 North America PD-1 and PD-L1 Immunotherapy Market Size by Application (2016-2027)
6.4 North America PD-1 and PD-L1 Immunotherapy Market Size by Country
6.4.1 North America PD-1 and PD-L1 Immunotherapy Market Size by Country (2016-2021)
6.4.2 North America PD-1 and PD-L1 Immunotherapy Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe PD-1 and PD-L1 Immunotherapy Market Size (2016-2027)
7.2 Europe PD-1 and PD-L1 Immunotherapy Market Size by Type
7.2.1 Europe PD-1 and PD-L1 Immunotherapy Market Size by Type (2016-2021)
7.2.2 Europe PD-1 and PD-L1 Immunotherapy Market Size by Type (2022-2027)
7.2.3 Europe PD-1 and PD-L1 Immunotherapy Market Size by Type (2016-2027)
7.3 Europe PD-1 and PD-L1 Immunotherapy Market Size by Application
7.3.1 Europe PD-1 and PD-L1 Immunotherapy Market Size by Application (2016-2021)
7.3.2 Europe PD-1 and PD-L1 Immunotherapy Market Size by Application (2022-2027)
7.3.3 Europe PD-1 and PD-L1 Immunotherapy Market Size by Application (2016-2027)
7.4 Europe PD-1 and PD-L1 Immunotherapy Market Size by Country
7.4.1 Europe PD-1 and PD-L1 Immunotherapy Market Size by Country (2016-2021)
7.4.2 Europe PD-1 and PD-L1 Immunotherapy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific PD-1 and PD-L1 Immunotherapy Market Size (2016-2027)
8.2 Asia-Pacific PD-1 and PD-L1 Immunotherapy Market Size by Type
8.2.1 Asia-Pacific PD-1 and PD-L1 Immunotherapy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific PD-1 and PD-L1 Immunotherapy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific PD-1 and PD-L1 Immunotherapy Market Size by Type (2016-2027)
8.3 Asia-Pacific PD-1 and PD-L1 Immunotherapy Market Size by Application
8.3.1 Asia-Pacific PD-1 and PD-L1 Immunotherapy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific PD-1 and PD-L1 Immunotherapy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific PD-1 and PD-L1 Immunotherapy Market Size by Application (2016-2027)
8.4 Asia-Pacific PD-1 and PD-L1 Immunotherapy Market Size by Region
8.4.1 Asia-Pacific PD-1 and PD-L1 Immunotherapy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific PD-1 and PD-L1 Immunotherapy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America PD-1 and PD-L1 Immunotherapy Market Size (2016-2027)
9.2 Latin America PD-1 and PD-L1 Immunotherapy Market Size by Type
9.2.1 Latin America PD-1 and PD-L1 Immunotherapy Market Size by Type (2016-2021)
9.2.2 Latin America PD-1 and PD-L1 Immunotherapy Market Size by Type (2022-2027)
9.2.3 Latin America PD-1 and PD-L1 Immunotherapy Market Size by Type (2016-2027)
9.3 Latin America PD-1 and PD-L1 Immunotherapy Market Size by Application
9.3.1 Latin America PD-1 and PD-L1 Immunotherapy Market Size by Application (2016-2021)
9.3.2 Latin America PD-1 and PD-L1 Immunotherapy Market Size by Application (2022-2027)
9.3.3 Latin America PD-1 and PD-L1 Immunotherapy Market Size by Application (2016-2027)
9.4 Latin America PD-1 and PD-L1 Immunotherapy Market Size by Country
9.4.1 Latin America PD-1 and PD-L1 Immunotherapy Market Size by Country (2016-2021)
9.4.2 Latin America PD-1 and PD-L1 Immunotherapy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa PD-1 and PD-L1 Immunotherapy Market Size (2016-2027)
10.2 Middle East & Africa PD-1 and PD-L1 Immunotherapy Market Size by Type
10.2.1 Middle East & Africa PD-1 and PD-L1 Immunotherapy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa PD-1 and PD-L1 Immunotherapy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa PD-1 and PD-L1 Immunotherapy Market Size by Type (2016-2027)
10.3 Middle East & Africa PD-1 and PD-L1 Immunotherapy Market Size by Application
10.3.1 Middle East & Africa PD-1 and PD-L1 Immunotherapy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa PD-1 and PD-L1 Immunotherapy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa PD-1 and PD-L1 Immunotherapy Market Size by Application (2016-2027)
10.4 Middle East & Africa PD-1 and PD-L1 Immunotherapy Market Size by Country
10.4.1 Middle East & Africa PD-1 and PD-L1 Immunotherapy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa PD-1 and PD-L1 Immunotherapy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca PD-1 and PD-L1 Immunotherapy Introduction
11.1.4 AstraZeneca Revenue in PD-1 and PD-L1 Immunotherapy Business (2016-2021)
11.1.5 AstraZeneca Recent Development
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Company Details
11.2.2 Bristol-Myers Squibb Business Overview
11.2.3 Bristol-Myers Squibb PD-1 and PD-L1 Immunotherapy Introduction
11.2.4 Bristol-Myers Squibb Revenue in PD-1 and PD-L1 Immunotherapy Business (2016-2021)
11.2.5 Bristol-Myers Squibb Recent Development
11.3 F. Hoffmann-La Roche
11.3.1 F. Hoffmann-La Roche Company Details
11.3.2 F. Hoffmann-La Roche Business Overview
11.3.3 F. Hoffmann-La Roche PD-1 and PD-L1 Immunotherapy Introduction
11.3.4 F. Hoffmann-La Roche Revenue in PD-1 and PD-L1 Immunotherapy Business (2016-2021)
11.3.5 F. Hoffmann-La Roche Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck PD-1 and PD-L1 Immunotherapy Introduction
11.4.4 Merck Revenue in PD-1 and PD-L1 Immunotherapy Business (2016-2021)
11.4.5 Merck Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer PD-1 and PD-L1 Immunotherapy Introduction
11.5.4 Pfizer Revenue in PD-1 and PD-L1 Immunotherapy Business (2016-2021)
11.5.5 Pfizer Recent Development
11.6 Roche
11.6.1 Roche Company Details
11.6.2 Roche Business Overview
11.6.3 Roche PD-1 and PD-L1 Immunotherapy Introduction
11.6.4 Roche Revenue in PD-1 and PD-L1 Immunotherapy Business (2016-2021)
11.6.5 Roche Recent Development
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Novartis Business Overview
11.7.3 Novartis PD-1 and PD-L1 Immunotherapy Introduction
11.7.4 Novartis Revenue in PD-1 and PD-L1 Immunotherapy Business (2016-2021)
11.7.5 Novartis Recent Development
11.8 Jiangsu HengRui Medicine
11.8.1 Jiangsu HengRui Medicine Company Details
11.8.2 Jiangsu HengRui Medicine Business Overview
11.8.3 Jiangsu HengRui Medicine PD-1 and PD-L1 Immunotherapy Introduction
11.8.4 Jiangsu HengRui Medicine Revenue in PD-1 and PD-L1 Immunotherapy Business (2016-2021)
11.8.5 Jiangsu HengRui Medicine Recent Development
11.9 Innovent
11.9.1 Innovent Company Details
11.9.2 Innovent Business Overview
11.9.3 Innovent PD-1 and PD-L1 Immunotherapy Introduction
11.9.4 Innovent Revenue in PD-1 and PD-L1 Immunotherapy Business (2016-2021)
11.9.5 Innovent Recent Development
11.10 Eli Lilly
11.10.1 Eli Lilly Company Details
11.10.2 Eli Lilly Business Overview
11.10.3 Eli Lilly PD-1 and PD-L1 Immunotherapy Introduction
11.10.4 Eli Lilly Revenue in PD-1 and PD-L1 Immunotherapy Business (2016-2021)
11.10.5 Eli Lilly Recent Development
11.11 GlaxoSmithKline
11.11.1 GlaxoSmithKline Company Details
11.11.2 GlaxoSmithKline Business Overview
11.11.3 GlaxoSmithKline PD-1 and PD-L1 Immunotherapy Introduction
11.11.4 GlaxoSmithKline Revenue in PD-1 and PD-L1 Immunotherapy Business (2016-2021)
11.11.5 GlaxoSmithKline Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global PD-1 and PD-L1 Immunotherapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of PD-1 inhibitor
Table 3. Key Players of PD-L1 inhibitor
Table 4. Global PD-1 and PD-L1 Immunotherapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global PD-1 and PD-L1 Immunotherapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global PD-1 and PD-L1 Immunotherapy Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global PD-1 and PD-L1 Immunotherapy Market Share by Regions (2016-2021)
Table 8. Global PD-1 and PD-L1 Immunotherapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global PD-1 and PD-L1 Immunotherapy Market Share by Regions (2022-2027)
Table 10. PD-1 and PD-L1 Immunotherapy Market Trends
Table 11. PD-1 and PD-L1 Immunotherapy Market Drivers
Table 12. PD-1 and PD-L1 Immunotherapy Market Challenges
Table 13. PD-1 and PD-L1 Immunotherapy Market Restraints
Table 14. Global PD-1 and PD-L1 Immunotherapy Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global PD-1 and PD-L1 Immunotherapy Market Share by Players (2016-2021)
Table 16. Global Top PD-1 and PD-L1 Immunotherapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in PD-1 and PD-L1 Immunotherapy as of 2020)
Table 17. Ranking of Global Top PD-1 and PD-L1 Immunotherapy Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by PD-1 and PD-L1 Immunotherapy Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players PD-1 and PD-L1 Immunotherapy Product Solution and Service
Table 21. Date of Enter into PD-1 and PD-L1 Immunotherapy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global PD-1 and PD-L1 Immunotherapy Market Size by Type (2016-2021) (US$ Million)
Table 24. Global PD-1 and PD-L1 Immunotherapy Revenue Market Share by Type (2016-2021)
Table 25. Global PD-1 and PD-L1 Immunotherapy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global PD-1 and PD-L1 Immunotherapy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global PD-1 and PD-L1 Immunotherapy Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global PD-1 and PD-L1 Immunotherapy Revenue Market Share by Application (2016-2021)
Table 29. Global PD-1 and PD-L1 Immunotherapy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global PD-1 and PD-L1 Immunotherapy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America PD-1 and PD-L1 Immunotherapy Market Size by Type (2016-2021) (US$ Million)
Table 32. North America PD-1 and PD-L1 Immunotherapy Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America PD-1 and PD-L1 Immunotherapy Market Size by Application (2016-2021) (US$ Million)
Table 34. North America PD-1 and PD-L1 Immunotherapy Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America PD-1 and PD-L1 Immunotherapy Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America PD-1 and PD-L1 Immunotherapy Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe PD-1 and PD-L1 Immunotherapy Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe PD-1 and PD-L1 Immunotherapy Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe PD-1 and PD-L1 Immunotherapy Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe PD-1 and PD-L1 Immunotherapy Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe PD-1 and PD-L1 Immunotherapy Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe PD-1 and PD-L1 Immunotherapy Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific PD-1 and PD-L1 Immunotherapy Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific PD-1 and PD-L1 Immunotherapy Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific PD-1 and PD-L1 Immunotherapy Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific PD-1 and PD-L1 Immunotherapy Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific PD-1 and PD-L1 Immunotherapy Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific PD-1 and PD-L1 Immunotherapy Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America PD-1 and PD-L1 Immunotherapy Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America PD-1 and PD-L1 Immunotherapy Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America PD-1 and PD-L1 Immunotherapy Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America PD-1 and PD-L1 Immunotherapy Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America PD-1 and PD-L1 Immunotherapy Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America PD-1 and PD-L1 Immunotherapy Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa PD-1 and PD-L1 Immunotherapy Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa PD-1 and PD-L1 Immunotherapy Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa PD-1 and PD-L1 Immunotherapy Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa PD-1 and PD-L1 Immunotherapy Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa PD-1 and PD-L1 Immunotherapy Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa PD-1 and PD-L1 Immunotherapy Market Size by Country (2022-2027) & (US$ Million)
Table 61. AstraZeneca Company Details
Table 62. AstraZeneca Business Overview
Table 63. AstraZeneca PD-1 and PD-L1 Immunotherapy Product
Table 64. AstraZeneca Revenue in PD-1 and PD-L1 Immunotherapy Business (2016-2021) & (US$ Million)
Table 65. AstraZeneca Recent Development
Table 66. Bristol-Myers Squibb Company Details
Table 67. Bristol-Myers Squibb Business Overview
Table 68. Bristol-Myers Squibb PD-1 and PD-L1 Immunotherapy Product
Table 69. Bristol-Myers Squibb Revenue in PD-1 and PD-L1 Immunotherapy Business (2016-2021) & (US$ Million)
Table 70. Bristol-Myers Squibb Recent Development
Table 71. F. Hoffmann-La Roche Company Details
Table 72. F. Hoffmann-La Roche Business Overview
Table 73. F. Hoffmann-La Roche PD-1 and PD-L1 Immunotherapy Product
Table 74. F. Hoffmann-La Roche Revenue in PD-1 and PD-L1 Immunotherapy Business (2016-2021) & (US$ Million)
Table 75. F. Hoffmann-La Roche Recent Development
Table 76. Merck Company Details
Table 77. Merck Business Overview
Table 78. Merck PD-1 and PD-L1 Immunotherapy Product
Table 79. Merck Revenue in PD-1 and PD-L1 Immunotherapy Business (2016-2021) & (US$ Million)
Table 80. Merck Recent Development
Table 81. Pfizer Company Details
Table 82. Pfizer Business Overview
Table 83. Pfizer PD-1 and PD-L1 Immunotherapy Product
Table 84. Pfizer Revenue in PD-1 and PD-L1 Immunotherapy Business (2016-2021) & (US$ Million)
Table 85. Pfizer Recent Development
Table 86. Roche Company Details
Table 87. Roche Business Overview
Table 88. Roche PD-1 and PD-L1 Immunotherapy Product
Table 89. Roche Revenue in PD-1 and PD-L1 Immunotherapy Business (2016-2021) & (US$ Million)
Table 90. Roche Recent Development
Table 91. Novartis Company Details
Table 92. Novartis Business Overview
Table 93. Novartis PD-1 and PD-L1 Immunotherapy Product
Table 94. Novartis Revenue in PD-1 and PD-L1 Immunotherapy Business (2016-2021) & (US$ Million)
Table 95. Novartis Recent Development
Table 96. Jiangsu HengRui Medicine Company Details
Table 97. Jiangsu HengRui Medicine Business Overview
Table 98. Jiangsu HengRui Medicine Revenue in PD-1 and PD-L1 Immunotherapy Business (2016-2021) & (US$ Million)
Table 99. Jiangsu HengRui Medicine Recent Development
Table 100. Innovent Company Details
Table 101. Innovent Business Overview
Table 102. Innovent PD-1 and PD-L1 Immunotherapy Product
Table 103. Innovent Revenue in PD-1 and PD-L1 Immunotherapy Business (2016-2021) & (US$ Million)
Table 104. Innovent Recent Development
Table 105. Eli Lilly Company Details
Table 106. Eli Lilly Business Overview
Table 107. Eli Lilly PD-1 and PD-L1 Immunotherapy Product
Table 108. Eli Lilly Revenue in PD-1 and PD-L1 Immunotherapy Business (2016-2021) & (US$ Million)
Table 109. Eli Lilly Recent Development
Table 110. GlaxoSmithKline Company Details
Table 111. GlaxoSmithKline Business Overview
Table 112. GlaxoSmithKline PD-1 and PD-L1 Immunotherapy Product
Table 113. GlaxoSmithKline Revenue in PD-1 and PD-L1 Immunotherapy Business (2016-2021) & (US$ Million)
Table 114. GlaxoSmithKline Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Global PD-1 and PD-L1 Immunotherapy Market Share by Type: 2020 VS 2027
Figure 2. PD-1 inhibitor Features
Figure 3. PD-L1 inhibitor Features
Figure 4. Global PD-1 and PD-L1 Immunotherapy Market Share by Application: 2020 VS 2027
Figure 5. Solid Tumors Case Studies
Figure 6. Blood-related Tumors Case Studies
Figure 7. PD-1 and PD-L1 Immunotherapy Report Years Considered
Figure 8. Global PD-1 and PD-L1 Immunotherapy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global PD-1 and PD-L1 Immunotherapy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global PD-1 and PD-L1 Immunotherapy Market Share by Regions: 2020 VS 2027
Figure 11. Global PD-1 and PD-L1 Immunotherapy Market Share by Regions (2022-2027)
Figure 12. Global PD-1 and PD-L1 Immunotherapy Market Share by Players in 2020
Figure 13. Global Top PD-1 and PD-L1 Immunotherapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in PD-1 and PD-L1 Immunotherapy as of 2020
Figure 14. The Top 10 and 5 Players Market Share by PD-1 and PD-L1 Immunotherapy Revenue in 2020
Figure 15. Global PD-1 and PD-L1 Immunotherapy Revenue Market Share by Type (2016-2021)
Figure 16. Global PD-1 and PD-L1 Immunotherapy Revenue Market Share by Type (2022-2027)
Figure 17. North America PD-1 and PD-L1 Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America PD-1 and PD-L1 Immunotherapy Market Share by Type (2016-2027)
Figure 19. North America PD-1 and PD-L1 Immunotherapy Market Share by Application (2016-2027)
Figure 20. North America PD-1 and PD-L1 Immunotherapy Market Share by Country (2016-2027)
Figure 21. United States PD-1 and PD-L1 Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada PD-1 and PD-L1 Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe PD-1 and PD-L1 Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe PD-1 and PD-L1 Immunotherapy Market Share by Type (2016-2027)
Figure 25. Europe PD-1 and PD-L1 Immunotherapy Market Share by Application (2016-2027)
Figure 26. Europe PD-1 and PD-L1 Immunotherapy Market Share by Country (2016-2027)
Figure 27. Germany PD-1 and PD-L1 Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France PD-1 and PD-L1 Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. PD-1 and PD-L1 Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy PD-1 and PD-L1 Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia PD-1 and PD-L1 Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic PD-1 and PD-L1 Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific PD-1 and PD-L1 Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific PD-1 and PD-L1 Immunotherapy Market Share by Type (2016-2027)
Figure 35. Asia-Pacific PD-1 and PD-L1 Immunotherapy Market Share by Application (2016-2027)
Figure 36. Asia-Pacific PD-1 and PD-L1 Immunotherapy Market Share by Region (2016-2027)
Figure 37. China PD-1 and PD-L1 Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan PD-1 and PD-L1 Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea PD-1 and PD-L1 Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia PD-1 and PD-L1 Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India PD-1 and PD-L1 Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia PD-1 and PD-L1 Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America PD-1 and PD-L1 Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America PD-1 and PD-L1 Immunotherapy Market Share by Type (2016-2027)
Figure 45. Latin America PD-1 and PD-L1 Immunotherapy Market Share by Application (2016-2027)
Figure 46. Latin America PD-1 and PD-L1 Immunotherapy Market Share by Country (2016-2027)
Figure 47. Mexico PD-1 and PD-L1 Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil PD-1 and PD-L1 Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa PD-1 and PD-L1 Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa PD-1 and PD-L1 Immunotherapy Market Share by Type (2016-2027)
Figure 51. Middle East & Africa PD-1 and PD-L1 Immunotherapy Market Share by Application (2016-2027)
Figure 52. Middle East & Africa PD-1 and PD-L1 Immunotherapy Market Share by Country (2016-2027)
Figure 53. Turkey PD-1 and PD-L1 Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia PD-1 and PD-L1 Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE PD-1 and PD-L1 Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. AstraZeneca Revenue Growth Rate in PD-1 and PD-L1 Immunotherapy Business (2016-2021)
Figure 57. Bristol-Myers Squibb Revenue Growth Rate in PD-1 and PD-L1 Immunotherapy Business (2016-2021)
Figure 58. F. Hoffmann-La Roche Revenue Growth Rate in PD-1 and PD-L1 Immunotherapy Business (2016-2021)
Figure 59. Merck Revenue Growth Rate in PD-1 and PD-L1 Immunotherapy Business (2016-2021)
Figure 60. Pfizer Revenue Growth Rate in PD-1 and PD-L1 Immunotherapy Business (2016-2021)
Figure 61. Roche Revenue Growth Rate in PD-1 and PD-L1 Immunotherapy Business (2016-2021)
Figure 62. Novartis Revenue Growth Rate in PD-1 and PD-L1 Immunotherapy Business (2016-2021)
Figure 63. Jiangsu HengRui Medicine Revenue Growth Rate in PD-1 and PD-L1 Immunotherapy Business (2016-2021)
Figure 64. Innovent Revenue Growth Rate in PD-1 and PD-L1 Immunotherapy Business (2016-2021)
Figure 65. Eli Lilly Revenue Growth Rate in PD-1 and PD-L1 Immunotherapy Business (2016-2021)
Figure 66. GlaxoSmithKline Revenue Growth Rate in PD-1 and PD-L1 Immunotherapy Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

Global PD-L1 Biomarker Testing Market Size, Status and Forecast 2021-2027
QFJ1-4669 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、PD-L1バイオマーカー検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PD-L1 IHC 22C3アッセイ、PD-L1 IHC 28-8アッセイ、PD-L1（SP142）アッセイ、PD-L1（S...

世界のPD-1＆PD-L1抗体市場規模・現状・予測（2021年-2027年）

Global PD-1 and PD-L1 Antibody Market Size, Status and Forecast 2021-2027
QFJ1-4667 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、PD-1＆PD-L1抗体の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PD-1阻害剤、PD-L1阻害剤）、用途別市場規模（固形腫瘍、血液関連腫瘍）、主要地域別市場規模（北米、アメリカ、欧州、アジア、...

世界の舌下アレルギー免疫療法市場規模・現状・予測（2021年-2027年）

Global Sublingual Allergy Immunotherapy Market Size, Status and Forecast 2021-2027
QFJ1-4913 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、舌下アレルギー免疫療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（錠剤、点滴）、用途別市場規模（鼻炎、喘息、湿疹、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イン...

世界のがん免疫療法市場規模・現状・予測（2021年-2027年）

Global Cancer Immunotherapy Market Size, Status and Forecast 2021-2027
QFJ1-5642 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、がん免疫療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（モノクローナル抗体、免疫チェックポイント阻害剤、免疫系モジュレーター、癌ワクチン）、用途別市場規模（肺がん、乳がん、結腸直腸がん、黒色腫、前...

世界の血液がん遺伝子改変免疫療法市場規模・現状・予測（2021年-2027年）

Global Gene Modifying Immunotherapy for Blood Cancer Market Size, Status and Forecast 2021-2027
QFJ1-4247 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、血液がん遺伝子改変免疫療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（CAR T細胞療法、TCRT細胞療法）、用途別市場規模（急性リンパ性白血病、慢性リンパ性白血病、B細胞リンパ腫、多発性骨髄腫、...

世界のCAR-T細胞免疫療法市場規模・現状・予測（2021年-2027年）

Global CAR T-Cell Immunotherapy Market Size, Status and Forecast 2021-2027
QFJ1-3967 2021年6月 123Pages
QYResearch社発行の本調査レポートでは、CAR-T細胞免疫療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（単剤療法、併用療法）、用途別市場規模（血液悪性腫瘍、固形悪性腫瘍）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、...

世界の樹状細胞癌ワクチン免疫療法市場規模・現状・予測（2021年-2027年）

Global Dendritic Cell Cancer Vaccine Immunotherapy Market Size, Status and Forecast 2021-2027
QFJ1-5694 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、樹状細胞癌ワクチン免疫療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（プロベンジ、アプセデン、CreaVax、その他）、用途別市場規模（小児科、成人用）、主要地域別市場規模（北米、アメリカ、欧州、...

世界の細胞ベース免疫療法市場規模・現状・予測（2021年-2027年）

Global Cell-Based Immunotherapy Market Size, Status and Forecast 2021-2027
QFJ1-3992 2021年6月 118Pages
QYResearch社発行の本調査レポートでは、細胞ベース免疫療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（自己細胞免疫療法、CAR（キメラ抗原受容体）T細胞療法、樹状細胞ベースワクチン療法）、用途別市場規模（病院、診療所、外来外科センター、...

アレルギー免疫療法のグローバル市場2021

Global Allergy Immunotherapy Sales Market Report 2021
QAF26946 2021年4月22日 137Pages
本市場調査資料では、世界のアレルギー免疫療法市場について種類別（皮下免疫療法、舌下免疫療法）、用途別（アレルギー性鼻炎、アレルギー性喘息、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価...

世界の脱感作市場規模・現状・予測（2021年-2027年）

Global Desensitization Market Size, Status and Forecast 2021-2027
QFJ1-5699 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、脱感作の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（皮下免疫療法、舌下免疫療法）、用途別市場規模（アレルギー性鼻炎、アレルギー性喘息、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本...

世界の血液がん遺伝子改変免疫療法市場規模・現状・予測（2021年-2027年） Genetic modification immunotherapy for blood cancer is a technique that involves genetic modification of immune system T cells.It allows T cells to recognize weakly expressed antigens in the blood or other organs of the body, such as tumor cells.This form of immunotherapy can be divided into two typ…
世界の舌下アレルギー免疫療法市場規模・現状・予測（2021年-2027年） Sublingual Allergy Immunotherapy is a method of treating allergies by giving a drug under the tongue. Market Analysis and Insights: Global Sublingual Allergy Immunotherapy Market The global Sublingual Allergy Immunotherapy market size is projected to reach US$ XX million by 2027, from US$ XX million…
世界のがん免疫療法市場規模・現状・予測（2021年-2027年） Immunotherapy, also called biologic therapy, is a type of cancer treatment that boosts the body's natural defenses to fight cancer. Market Analysis and Insights: Global Cancer Immunotherapy Market The global Cancer Immunotherapy market size is projected to reach US$ 135140 million by 2027, from US$ …
世界のCAR-T細胞免疫療法市場規模・現状・予測（2021年-2027年） CAR T-Cell Immunotherapy is a new type of cancer treatment. This emerging treatment represents one of the biggest breakthroughs since the introduction of chemotherapy. T cells is a type of white blood cell extracted from the patient’s blood by doctors, and added an artificial receptor to their surfa…
世界の樹状細胞癌ワクチン免疫療法市場規模・現状・予測（2021年-2027年） Dendritic cells (DCs) are one of the major antigen-presenting cells found in lymphoid organs. Main function of the dendritic cells is antigen display and activation of T-cells. Antigen display presents the identity of pathogen to T-cells for their identification and elimination from the body. These …